ResMed addresses takeover rumours
Tuesday, 01 July, 2008
ResMed (ASX:RMD) responded today to reports in The Age and Australian Financial Review newspapers of a rumoured takeover bid by Germany's Linde Group.
In a statement to the stock exchange, ResMed said it had a policy of not commenting on market rumours, but also told the ASX the company was not aware of any information it was required to disclose to the market.
ResMed's disclosure follows reports in The Age of rumours that the company "is being stalked by industrial and medical gas giants the Linde Group", and in the Australian Financial Review referring to "rumours of an agreed cash bid". Both reports were published today.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
